Skip to main content
. 2020 Oct 15;5(20):e139987. doi: 10.1172/jci.insight.139987

Figure 6. Effect of systemic tail vein administration of TL02-59 on autologous blood microinjection–induced thalamic pain genesis.

Figure 6

TL02-59 or vehicle was given 30 minutes before autologous blood or saline microinjection and once daily thereafter. Effect of systemic administration of TL02-59 (15 mg/kg) or vehicle on paw withdrawal frequencies to 0.07 g (A and E) and 0.4 g (B and F) von Frey filaments and paw withdrawal latencies to heat (C and G) and cold (D) stimuli on days 1 and 3 after thalamic microinjection of autologous blood or saline on the contralateral (A–D) and ipsilateral (E–G) sides. n = 8 mice/group. Two-way ANOVA with repeated measures followed by post hoc Tukey’s test. **P < 0.01 versus the corresponding baseline (day –1). ##P < 0.01 versus the autologous blood plus vehicle group at the corresponding days.